Your browser doesn't support javascript.
loading
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Chapman, Michael A; Sive, Jonathan; Ambrose, John; Roddie, Claire; Counsell, Nicholas; Lach, Anna; Abbasian, Mahnaz; Popat, Rakesh; Cavenagh, Jamie D; Oakervee, Heather; Streetly, Matthew J; Schey, Stephen; Koh, Mickey; Willis, Fenella; Virchis, Andres E; Crowe, Josephine; Quinn, Michael F; Cook, Gordon; Crawley, Charles R; Pratt, Guy; Cook, Mark; Braganza, Nivette; Adedayo, Toyin; Smith, Paul; Clifton-Hadley, Laura; Owen, Roger G; Sonneveld, Pieter; Keats, Jonathan J; Herrero, Javier; Yong, Kwee.
Afiliação
  • Chapman MA; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Sive J; Department of Haematology, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Ambrose J; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Roddie C; Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, London, United Kingdom.
  • Counsell N; Department of Haematology, University College London Hospitals, London, United Kingdom.
  • Lach A; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Abbasian M; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.
  • Popat R; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.
  • Cavenagh JD; Department of Haematology, University College London Hospitals, London, United Kingdom.
  • Oakervee H; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Streetly MJ; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Schey S; Department of Haematology, Guys and St. Thomas' Hospital, London, United Kingdom.
  • Koh M; Department of Haematology, Kings College Hospital, London, United Kingdom.
  • Willis F; Department of Haematology, St. George's Hospital, London, United Kingdom.
  • Virchis AE; Department of Haematology, St. George's Hospital, London, United Kingdom.
  • Crowe J; Department of Haematology, Royal Free London, Barnet and Chase Farm Hospitals, London, United Kingdom.
  • Quinn MF; Department of Haematology, Royal United Hospitals Bath, Bath, United Kingdom.
  • Cook G; Department of Haematology, Belfast City Hospital, Belfast, United Kingdom.
  • Crawley CR; Department of Haematology, St. James's University Hospital, Leeds, United Kingdom.
  • Pratt G; Department of Haematology, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Cook M; Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom.
  • Braganza N; Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom.
  • Adedayo T; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Smith P; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Clifton-Hadley L; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Owen RG; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Sonneveld P; Haematological Malignancy Diagnostic Service, St. James' University Hospital, Leeds, United Kingdom.
  • Keats JJ; Erasmus Medical Centre, Rotterdam, The Netherlands; and.
  • Herrero J; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ.
  • Yong K; Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, London, United Kingdom.
Blood ; 132(20): 2154-2165, 2018 11 15.
Article em En | MEDLINE | ID: mdl-30181174
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bortezomib / Lenalidomida / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bortezomib / Lenalidomida / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido